A demonstration of the Cocoon® platform: a bespoke solution to minimize manual touchpoints in cell therapy manufacturing

Published: 21 April 2021
FastFacts
Joseph O’Connor
Joseph O’Connor
Senior Scientist, Personalized Medicine Business Unit, Lonza
Joseph O’Connor, PhD, is currently a senior scientist in process development for Lonza’s Personalized Medicine Business Unit. His focus is on translating and optimizing manual autologous cell therapies into the Cocoon® Platform, a closed and automated cell therapy manufacturing solution. Joseph earned a doctorate in chemical engineering from the Pennsylvania State University while researching the mechanical regulation of gene expression. He has been with Lonza since 2017.

Watch the demonstration video or read the poster to learn how the Cocoon® platform streamlines patient-scale cell therapy manufacturing by minimizing manual touchpoints at every stage:

  • Sample loading
  • Activation
  • Transduction or transfection
  • Expansion
  • Harvest

About the speaker

Joseph O’Connor, PhD, is currently a senior scientist in process development for Lonza’s Personalized Medicine Business Unit. His focus is on translating and optimizing manual autologous cell therapies into the Cocoon® Platform, a closed and automated cell therapy manufacturing solution. Joseph earned a doctorate in chemical engineering from the Pennsylvania State University while researching the mechanical regulation of gene expression. He has been with Lonza since 2017.

    Please note all fields marked with an * are mandatory

    View article

    Already registered? Login

    If you have any problem accessing our content, please email info@insights.bio